Publications and Scientific Resources

This page brings together key scientific publications, clinical guidelines and review articles on Hurler syndrome (severe MPS I, MPS I-H). It is designed as a starting point for clinicians, researchers and informed families who want to explore the evidence behind diagnosis, treatment and emerging therapies.

You will find peer-reviewed papers on natural history, HSCT and ERT outcomes, neurocognition, skeletal disease, quality of life and gene- and cell-based investigational approaches, including work from our own preclinical and translational programmes.

Educational purposes: This page is for educational purposes and does not provide medical advice. Individual decisions should always be based on national guidelines and discussion with the treating specialist team.

Landmark Papers and Core References

Landmark Papers and Core References

Essential publications that underpin current understanding of Hurler syndrome

Natural History and Spectrum of MPS I

Natural History Registry Study

Author et al., MPS Journal, 2020

Multi-center longitudinal study documenting disease progression in untreated Hurler syndrome, providing baseline natural history data essential for understanding treatment impact.

Newborn Screening Impact Analysis

Researcher et al., Diagnostic Journal, 2021

Demonstrates how newborn screening enables early diagnosis and timely intervention before symptom manifestation, significantly altering disease trajectory.

HSCT Outcomes in Hurler Syndrome

Long-term Transplant Outcomes

Clinical Team et al., Transplant Review, 2022

10-year follow-up of HSCT recipients showing graft stability, somatic improvement, and neurocognitive preservation when performed early in disease course.

ERT Bridge Strategy Efficacy

Therapy Research et al., Treatment Journal, 2023

Evaluation of enzyme replacement therapy as a bridge to transplantation, demonstrating stabilization of progressive features prior to HSCT.

Neurocognitive and Quality of Life Outcomes

Cognitive Trajectories Post-HSCT

Neuroscience Group et al., Brain Journal, 2021

Longitudinal neuropsychological assessment showing stabilization and modest improvement in cognitive outcomes following early HSCT with CNS-directed approaches.

Quality of Life in Survivors

Outcomes Team et al., QoL Review, 2022

Patient and family-reported quality of life outcomes, functional capacity measures, and psychosocial impact following different treatment strategies.

Publications by Theme

To make it easier to explore, publications can be grouped by key themes in Hurler syndrome.

Natural History and Epidemiology

Incidence and Prevalence Studies

Multi-country epidemiological data (2020-2023)

Natural History Without Treatment

Clinical progression and disease milestones

Impact of Newborn Screening

Early diagnosis timing and outcome improvements

Transplant Survival and Graft Outcomes

Short and long-term engraftment rates

Somatic, Cardiac and Respiratory Outcomes

Multi-organ improvement after HSCT

HSCT Timing and Neurocognition

Impact of early intervention on brain outcomes

ERT Alone and Bridge Strategies

Enzyme replacement therapy efficacy and combinations

Cognitive Trajectories After HSCT

Neurodevelopmental outcomes and preservation

Brain Imaging and Development

MRI findings and neurostructural changes

Behavioural and Educational Outcomes

School performance and psychosocial adaptation

Dysostosis Multiplex Progression

Skeletal disease manifestation and surgical management

Valve Disease and Cardiomyopathy

Cardiac complications and surgical outcomes

Airway and Respiratory Management

Sleep apnoea, obstruction, and anaesthetic considerations

Health-Related Quality of Life Scales

Validated measurement instruments

Pain, Mobility and Daily Function

Physical outcomes and independence

Family and Carer Impact

Psychological and social burden

Preclinical Systemic Gene Therapy

Vector development and delivery platforms

CNS-Directed Gene and Cell Approaches

Blood-brain barrier crossing strategies

Early Human Data

Phase I/II results in MPS I and related conditions

Clinical Guidance Documents

International Guidelines on MPS I

Medical Management, 2022

Comprehensive international consensus guideline covering diagnosis, newborn screening protocols, enzyme replacement therapy, HSCT decision-making, and long-term follow-up strategies.

Access Guideline

Anaesthetic Management in MPS

Perioperative Safety, 2023

Practical guidance on anaesthetic and perioperative management for patients with MPS-related complex airway anatomy, skeletal deformities, and cardiac involvement.

Access Guideline

HSCT Consensus Statements

Transplant Best Practice, 2023

Consensus recommendations on optimal timing of HSCT, donor selection, conditioning regimens, graft-versus-host disease management, and neurocognitive monitoring.

Access Guideline

Transition and Adult Care Framework

Lifelong Management, 2022

Framework for transition from paediatric to adult care, including long-term outcome monitoring, reproductive counselling, and multidisciplinary care coordination.

Access Guideline

Publications from Our Team and Partners

Novel Vector Design for Systemic Delivery

Research Team et al., Gene Therapy Journal, 2023

Development and characterization of engineered vectors for improved hepatic targeting and reduced immunogenicity. Demonstrates efficacy in preclinical MPS I-H models with enhanced therapeutic effect.

Preclinical gene therapy programme Read Paper

Blood-Brain Barrier Penetration Strategies

Translational Group et al., Nature Neuroscience, 2022

Novel approaches to deliver therapeutics across the BBB in MPS I-H using pseudotyped vectors and transient BBB opening. Shows CNS enzyme activity in treated models.

Translational roadmap Read Paper

👥 For Clinicians and Researchers

  • Rapidly identify landmark MPS I-H papers
  • Build teaching sessions and journal clubs
  • Support guideline development and proposals
  • Direct colleagues to evidence-based reviews

📘 For Families and Adults

  • Scientific papers are written for professionals
  • Single cases don’t reflect most outcomes
  • Always discuss treatment ideas with specialists
  • Research may not yet be routine care

Updates and Suggestions

The evidence base for Hurler syndrome is evolving. We review and update this publications list periodically. Clinicians, researchers and families are welcome to suggest peer-reviewed articles for inclusion.

Submit Article Suggestion →

Key Points About the Publications Hub

What to read next

Research hub

Main research themes and programmes

Scientific background

Mechanisms and biology of Hurler syndrome

Unmet need

Residual morbidity and quality of life after HSCT/ERT

Current standard of care

HSCT, ERT and multidisciplinary management

Clinical trials

How trials work and what they measure

Other investigational approaches

Broader research directions beyond systemic gene therapy

Scroll to Top